ATLANTA, Ga.-Celliance, the third operating division of Serologicals Corp. (www.serologicals.com), has been formed to focus on providing recombinant human insulin to biopharmaceutical manufacturers. The new division features a self-contained Class 7 cleanroom that has been built specifically for the critical insulin packaging process.
 |
Featuring strict temperature and humidity control, the cleanroom has been built to allow insulin to be stored-from delivery to post repack-in a single isolated area. The company says the process flow guarantees isolation from other products, preventing the possibility of contamination during repackaging.
 |
Recombinant insulin, used to treat diabetes, is purified from bacteria, which is considered a safer and purer source than material purified from a human or animal pancreas.